Adiponectin is considered a modulator of glucose metabolism. Hypoadiponectinemia was reported to be associated with glucose metabolism and metabolic syndrome, and had been found in patients with hepatitis B virus (HBV) and hepatitis C virus infections. However, little is known about the role of adiponectin in patients with HBV infection. Fifty-five patients with HBV infection and 52 healthy individuals were included in this study. We found that serum adiponectin was significantly lower in patients with HBV infection. We also found that HBV-infected patients with hemoglobin A1C ≥6.5% had a lower adiponectin level than those with hemoglobin A1C <6.5%. In conclusion, hypoadiponectinemia occurs in patients with HBV infection, and adiponectin may play a role in the pathogenesis of glucose metabolism in these patients.

Wen-Tung Hsu

Keng-Yi Wu

Wu-Hsien Kuo

Wen-Hsiu Hsu

Yu-Lian Lai

Yi-Yu Tu

Kwang-Yang Tsai

Li-Mien Chen

Biomarkers and Genomic Medicine

Serum adiponectin and glucose in patients with hepatitis B virus infection

血清脂联素与乙型肝炎病毒感染患者的血糖水平

Serum adiponectin and glucose in patients with hepatitis B virus infection

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info